Hospital
Beaver Dam Community Hospitals INC
Beaver Dam Community Hospitals INC was paid $10.58M by Medicaid between Jan 2018 and Dec 2024, across 244 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 17% of everything it billed.
33Billing provider infoBEAVER DAM COMMUNITY HOSPITALS INC
BEAVER DAM, WI 53916
BEAVER DAM, WI 53916
33aNPI1023187416assigned 11/07/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.58M
24GClaims467,008
24DCodes billed244
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Wisconsin
Rank by total paid#17 of 60
Median peer was paid$2.90M
This provider vs. median3.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MUNSON, JOLYN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 63,514 | $1.56M | |
| 2019 | 67,158 | $1.56M | |
| 2020 | 60,200 | $1.38M | |
| 2021 | 72,615 | $1.53M | |
| 2022 | 68,299 | $1.44M | |
| 2023 | 76,445 | $1.69M | |
| 2024incomplete | 58,777 | $1.43M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 34,257 | 28,540 | $1.79M |
| 96361 | Intravenous infusion, hydration; each additional hour | 10% | 10,210 | 7,711 | $1.09M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.0% | 13,788 | 11,569 | $635K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.6% | 10,032 | 8,029 | $492K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.3% | 7,677 | 6,659 | $450K |
| 80053 | Comprehensive metabolic panel | 3.9% | 20,252 | 16,261 | $416K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.6% | 7,223 | 6,280 | $386K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.1% | 5,352 | 4,652 | $330K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.5% | 6,319 | 5,404 | $267K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.4% | 2,503 | 2,237 | $256K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.9% | 2,909 | 2,563 | $201K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.8% | 4,284 | 3,888 | $195K |
232 more codes
| 70450 | Computed tomography, head or brain; without contrast material | 1.8% | 3,127 | $191K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.7% | 8,173 | $181K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.7% | 2,940 | $180K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.6% | 3,964 | $171K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 23,656 | $159K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.5% | 4,331 | $157K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.3% | 2,934 | $141K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.2% | 1,896 | $131K |
| 99203 | Doctor's office visit, new patient (routine) | 1.2% | 2,424 | $123K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 2,757 | $121K |
| 80305 | 1.1% | 7,142 | $111K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,474 | $94K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 5,087 | $93K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,738 | $87K |
| 81003 | <1% | 2,104 | $82K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,778 | $72K |
| 81025 | <1% | 6,340 | $70K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,897 | $66K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,090 | $58K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,405 | $57K |
| 99000 | <1% | 2,989 | $56K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 842 | $56K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 7,364 | $54K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,221 | $53K |
| 81001 | <1% | 14,595 | $51K | |
| 84484 | <1% | 6,457 | $49K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,415 | $48K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 710 | $47K |
| 80061 | Lipid panel | <1% | 3,437 | $45K |
| 87660 | <1% | 2,108 | $41K | |
| 87480 | <1% | 2,108 | $39K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 832 | $37K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 580 | $37K |
| 84702 | <1% | 871 | $35K | |
| 83690 | <1% | 5,992 | $34K | |
| 87510 | <1% | 2,108 | $33K | |
| 87430 | <1% | 695 | $33K | |
| 76830 | Ultrasound, transvaginal | <1% | 875 | $32K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,702 | $31K |
| 83605 | <1% | 3,491 | $29K | |
| 82948 | <1% | 1,194 | $28K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 423 | $28K |
| 85610 | <1% | 3,768 | $27K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 652 | $25K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,591 | $24K |
| 82550 | <1% | 3,904 | $24K | |
| 83880 | <1% | 1,205 | $24K | |
| 83735 | <1% | 5,075 | $23K | |
| 59050 | <1% | 328 | $22K | |
| 87186 | <1% | 2,394 | $22K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 283 | $21K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 327 | $21K |
| 84145 | <1% | 1,213 | $19K | |
| 82950 | <1% | 405 | $19K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 559 | $19K |
| 73630 | <1% | 1,922 | $18K | |
| 82553 | <1% | 3,667 | $18K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 960 | $17K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 263 | $16K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 608 | $15K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 648 | $15K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 484 | $14K |
| 81513 | <1% | 183 | $13K | |
| 87077 | <1% | 1,984 | $13K | |
| 85379 | <1% | 1,736 | $13K | |
| 97161 | <1% | 422 | $12K | |
| 87634 | <1% | 222 | $12K | |
| 86803 | <1% | 725 | $12K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 236 | $12K |
| 87507 | <1% | 29 | $11K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 136 | $11K |
| 87040 | <1% | 1,587 | $10K | |
| 82565 | <1% | 520 | $10K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 181 | $9K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 10,614 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,163 | $8K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 1,064 | $8K |
| 93976 | <1% | 313 | $8K | |
| 20610 | <1% | 150 | $8K | |
| 73610 | <1% | 1,377 | $7K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 175 | $7K |
| 73030 | <1% | 890 | $7K | |
| 73110 | <1% | 556 | $7K | |
| 87081 | <1% | 681 | $7K | |
| 85730 | <1% | 1,609 | $7K | |
| 71045 | Radiologic examination, chest; single view | <1% | 5,878 | $7K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 243 | $6K |
| 97162 | <1% | 186 | $6K | |
| 0240U | <1% | 209 | $6K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 196 | $6K |
| 86140 | <1% | 1,187 | $6K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 11,048 | $6K |
| 84703 | <1% | 610 | $5K | |
| 87070 | <1% | 357 | $5K | |
| 87481 | <1% | 183 | $5K | |
| 73130 | <1% | 729 | $5K | |
| 84439 | <1% | 620 | $5K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 41 | $5K |
| 99205 | Prolong outpt/office vis | <1% | 65 | $4K |
| 86780 | <1% | 376 | $4K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 102 | $4K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 85 | $4K |
| 59025 | Fetal non-stress test | <1% | 52 | $4K |
| 82728 | <1% | 235 | $4K | |
| 80055 | <1% | 29 | $4K | |
| 88142 | <1% | 200 | $4K | |
| 82962 | <1% | 1,480 | $4K | |
| 80050 | General health panel | <1% | 1,320 | $3K |
| 85027 | <1% | 679 | $3K | |
| 90715 | <1% | 403 | $3K | |
| 82077 | <1% | 371 | $3K | |
| 94664 | <1% | 120 | $3K | |
| 83540 | <1% | 240 | $3K | |
| 97035 | <1% | 126 | $3K | |
| 0001A | <1% | 184 | $3K | |
| 85652 | <1% | 919 | $3K | |
| 0002A | <1% | 152 | $3K | |
| 93971 | <1% | 91 | $3K | |
| 12001 | <1% | 36 | $3K | |
| 87340 | <1% | 318 | $3K | |
| 86703 | <1% | 195 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 7,736 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 26 | $2K |
| G0378 | Hospital observation service, per hour | <1% | 515 | $2K |
| 73562 | <1% | 590 | $2K | |
| 85014 | <1% | 366 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,306 | $2K |
| 90674 | <1% | 217 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 22,728 | $2K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 54 | $2K |
| 82570 | <1% | 183 | $2K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 168 | $2K |
| 86901 | <1% | 644 | $1K | |
| 86900 | <1% | 626 | $1K | |
| 83550 | <1% | 206 | $1K | |
| 80329 | <1% | 755 | $1K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 222 | $1K |
| 86850 | <1% | 359 | $1K | |
| 90686 | <1% | 50 | $1K | |
| 72100 | <1% | 322 | $1K | |
| Q9962 | High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml | <1% | 1,321 | $970.88 |
| 80143 | <1% | 82 | $960.24 | |
| 80179 | <1% | 81 | $929.67 | |
| 91322 | <1% | 21 | $928.64 | |
| 85018 | <1% | 273 | $882.17 | |
| 70486 | <1% | 13 | $761.41 | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 14 | $750.66 |
| 82247 | <1% | 22 | $712.32 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 21 | $711.60 |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 14 | $688.73 |
| 80074 | <1% | 15 | $664.47 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 12 | $659.38 |
| 86762 | <1% | 16 | $645.44 | |
| 76642 | <1% | 17 | $637.69 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,584 | $629.00 |
| 87205 | <1% | 226 | $617.67 | |
| 86704 | <1% | 68 | $604.03 | |
| 86708 | <1% | 66 | $582.62 | |
| 86706 | <1% | 72 | $571.87 | |
| 90480 | <1% | 33 | $533.34 | |
| 73502 | <1% | 63 | $511.93 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 12 | $507.32 |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 26 | $449.89 |
| 73560 | <1% | 77 | $425.85 | |
| G0008 | Administration of influenza virus vaccine | <1% | 246 | $405.56 |
| 36592 | <1% | 4,252 | $402.92 | |
| 96376 | <1% | 2,976 | $383.62 | |
| 87493 | <1% | 13 | $354.27 | |
| 93017 | <1% | 12 | $337.95 | |
| 0031A | <1% | 26 | $337.47 | |
| 0004A | <1% | 22 | $293.51 | |
| 84100 | <1% | 86 | $276.39 | |
| 82803 | <1% | 17 | $273.45 | |
| 74018 | <1% | 79 | $202.31 | |
| 82043 | <1% | 41 | $193.44 | |
| 90656 | <1% | 31 | $191.46 | |
| 82607 | <1% | 12 | $189.81 | |
| 97163 | <1% | 14 | $189.63 | |
| 99441 | <1% | 34 | $188.37 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,657 | $160.39 |
| 80320 | <1% | 1,340 | $149.03 | |
| 73140 | <1% | 49 | $130.24 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 210 | $126.00 |
| 73590 | <1% | 13 | $125.82 | |
| 84550 | <1% | 43 | $118.39 | |
| 84450 | <1% | 15 | $101.11 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,293 | $89.16 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,178 | $75.41 |
| 82248 | <1% | 18 | $70.50 | |
| 91307 | <1% | 49 | $69.76 | |
| 11721 | <1% | 12 | $57.63 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 2,541 | $54.89 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 17 | $51.31 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 16 | $46.83 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,549 | $40.10 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 546 | $34.45 |
| 91300 | <1% | 224 | $32.10 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,378 | $30.28 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | <1% | 1,235 | $12.73 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 578 | $12.73 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 277 | $11.84 |
| 97597 | <1% | 21 | $11.60 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 563 | $9.97 |
| J2704 | Injection, propofol, 10 mg | <1% | 955 | $6.97 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,739 | $2.43 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,300 | $1.98 |
| J3490 | Unclassified drugs | <1% | 1,209 | $1.71 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 860 | $0.91 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 2,397 | $0.77 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,057 | $0.17 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 1,367 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 57 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 521 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 255 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 929 | $0.00 |
| A9270 | Non-covered item or service | 0% | 680 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 141 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 13 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 15 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 0% | 13 | $0.00 |
| 51798 | 0% | 15 | $0.00 | |
| J3535 | Drug administered through a metered dose inhaler | 0% | 37 | $0.00 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 0% | 18 | $0.00 |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 0% | 15 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 136 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 0% | 44 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 20 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 20 | $0.00 |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 26 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 43 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 61 | $0.00 |
| E0114 | Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMUNSON, JOLYN (VP REVENUE CYCLE OPERATIONS)
Parent organizationMARSHFIELD CLINIC HEALTH SYSTEM INC
| Provider | Location | Paid |
|---|---|---|
| MCHS Hospitals INC | Marshfield, WI | $45.31M |
| Marshfield Clinic INC | Marshfield, WI | $19.61M |
| MCHS Hospitals INC | Eau Claire, WI | $12.41M |
| MCHS Hospitals INC | Marshfield, WI | $11.82M |
| Dickinson County Healthcare System | Iron Mountain, MI | $10.23M |
| MCHS Hospitals INC | Ladysmith, WI | $7.36M |
| MCHS Hospitals INC | Weston, WI | $6.40M |
| MCHS Hospitals INC | Eau Claire, WI | $4.14M |
| MCHS Hospitals INC | Minocqua, WI | $2.90M |
| Dickinson County Healthcare System | Iron Mountain, MI | $2.44M |
| Dickinson County Healthcare System | Iron Mountain, MI | $2.29M |
| MCHS Hospitals INC | Wausau, WI | $1.84M |
| MCHS Hospitals INC | Weston, WI | $1.22M |
| MCHS Hospitals INC | Minocqua, WI | $1.16M |
| MCHS Hospitals INC | Marshfield, WI | $988K |
| MCHS Hospitals INC | Ladysmith, WI | $867K |
| Beaver Dam Community Hospitals INC | Beaver Dam, WI | $847K |
| Dickinson County Healthcare System | Iron Mountain, MI | $648K |
| MCHS Hospitals INC | Marshfield, WI | $563K |
| MCHS Hospitals INC | Minocqua, WI | $338K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.